Page 7 - Rating Scale News Today

An FDA panel has voted on the question of whether evidence supports the approval of sodium phenylbutyrate/taurursodiol (AMX0035) for ALS.

Post Traumatic Stress Disorder (PTSD) was more common in children who had suffered physical trauma than in adults. Despite its prevalence, the prevalence and factors associated with PTSD in pediatric patients with physical trauma are unknown in Ethiopia. As a result, the purpose of this study was to determine the prevalence of PTSD and associated factors among pediatric patients with physical trauma who attended Northwest Amhara referral hospitals. An institutional-based cross-sectional study de...

Patients with amyotrophic lateral sclerosis carrying variants of the gene glucocerebrosidase were more likely to show cognitive decline compared to noncarriers.

Study finds that low-dose medications for ADHD are not associated with changes in thyroid or growth hormone levels among children aged 6 to 12 years.

NeuroSense CEO Alon Ben-Noon reveals the target patient population and outcome measures of a planned Phase IIb ALS trial of PrimeC.

Patients with amyotrophic lateral sclerosis carrying variants of the gene glucocerebrosidase were more likely to show cognitive decline compared to noncarriers.

An FDA panel has voted on the question of whether evidence supports the approval of sodium phenylbutyrate/taurursodiol (AMX0035) for ALS.

A US Food and Drug Administration advisory committee is unconvinced by that a new drug for amyotrophic lateral sclerosis is effective.

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

BrainStorm is generating stem cells to test its ALS drug in a genetic subpopulation after missing the mark in a Phase III trial.